Global Clindamycin Phosphate Topical Market Research Report 2023

Publication ID:

PB510233813

Publication Date:

October 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Clindamycin Phosphate Topical, USP 1% is indicated in the treatment of acne vulgaris.
The global Clindamycin Phosphate Topical market is projected to reach US$ 358.9 million in 2029, increasing from US$ 224 million in 2022, with the CAGR of 6.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Clindamycin Phosphate Topical 91制片厂.
Key manufacturers engaged in the Clindamycin Phosphate Topical industry include Pfizer, Perrigo, Mylan, Ortho Dermatologics, Taro Pharmaceutical, Akorn, Teligent, Zydus Pharmaceuticals and North China Pharmaceutical Group, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Clindamycin Phosphate Topical were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Clindamycin Phosphate Topical market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Clindamycin Phosphate Topical market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Pfizer
Perrigo
Mylan
Ortho Dermatologics
Taro Pharmaceutical
Akorn
Teligent
Zydus Pharmaceuticals
North China Pharmaceutical Group
Segment by Type
Gel
Topical Solution
Foam
Segment by Application
Men
Women
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Clindamycin Phosphate Topical report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Clindamycin Phosphate Topical Market Overview
1.1 Product Overview and Scope of Clindamycin Phosphate Topical
1.2 Clindamycin Phosphate Topical Segment by Type
1.2.1 Global Clindamycin Phosphate Topical Market Value Comparison by Type (2023-2029)
1.2.2 Gel
1.2.3 Topical Solution
1.2.4 Foam
1.3 Clindamycin Phosphate Topical Segment by Application
1.3.1 Global Clindamycin Phosphate Topical Market Value by Application: (2023-2029)
1.3.2 Men
1.3.3 Women
1.4 Global Clindamycin Phosphate Topical Market Size Estimates and Forecasts
1.4.1 Global Clindamycin Phosphate Topical Revenue 2018-2029
1.4.2 Global Clindamycin Phosphate Topical Sales 2018-2029
1.4.3 Global Clindamycin Phosphate Topical Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Clindamycin Phosphate Topical Market Competition by Manufacturers
2.1 Global Clindamycin Phosphate Topical Sales Market Share by Manufacturers (2018-2023)
2.2 Global Clindamycin Phosphate Topical Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Clindamycin Phosphate Topical Average Price by Manufacturers (2018-2023)
2.4 Global Clindamycin Phosphate Topical Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Clindamycin Phosphate Topical, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Clindamycin Phosphate Topical, Product Type & Application
2.7 Clindamycin Phosphate Topical Market Competitive Situation and Trends
2.7.1 Clindamycin Phosphate Topical Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Clindamycin Phosphate Topical Players Market Share by Revenue
2.7.3 Global Clindamycin Phosphate Topical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Clindamycin Phosphate Topical Retrospective Market Scenario by Region
3.1 Global Clindamycin Phosphate Topical Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Clindamycin Phosphate Topical Global Clindamycin Phosphate Topical Sales by Region: 2018-2029
3.2.1 Global Clindamycin Phosphate Topical Sales by Region: 2018-2023
3.2.2 Global Clindamycin Phosphate Topical Sales by Region: 2024-2029
3.3 Global Clindamycin Phosphate Topical Global Clindamycin Phosphate Topical Revenue by Region: 2018-2029
3.3.1 Global Clindamycin Phosphate Topical Revenue by Region: 2018-2023
3.3.2 Global Clindamycin Phosphate Topical Revenue by Region: 2024-2029
3.4 North America Clindamycin Phosphate Topical Market Facts & Figures by Country
3.4.1 North America Clindamycin Phosphate Topical Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Clindamycin Phosphate Topical Sales by Country (2018-2029)
3.4.3 North America Clindamycin Phosphate Topical Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Clindamycin Phosphate Topical Market Facts & Figures by Country
3.5.1 Europe Clindamycin Phosphate Topical Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Clindamycin Phosphate Topical Sales by Country (2018-2029)
3.5.3 Europe Clindamycin Phosphate Topical Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Clindamycin Phosphate Topical Market Facts & Figures by Country
3.6.1 Asia Pacific Clindamycin Phosphate Topical Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Clindamycin Phosphate Topical Sales by Country (2018-2029)
3.6.3 Asia Pacific Clindamycin Phosphate Topical Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Clindamycin Phosphate Topical Market Facts & Figures by Country
3.7.1 Latin America Clindamycin Phosphate Topical Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Clindamycin Phosphate Topical Sales by Country (2018-2029)
3.7.3 Latin America Clindamycin Phosphate Topical Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Clindamycin Phosphate Topical Market Facts & Figures by Country
3.8.1 Middle East and Africa Clindamycin Phosphate Topical Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Clindamycin Phosphate Topical Sales by Country (2018-2029)
3.8.3 Middle East and Africa Clindamycin Phosphate Topical Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Clindamycin Phosphate Topical Sales by Type (2018-2029)
4.1.1 Global Clindamycin Phosphate Topical Sales by Type (2018-2023)
4.1.2 Global Clindamycin Phosphate Topical Sales by Type (2024-2029)
4.1.3 Global Clindamycin Phosphate Topical Sales Market Share by Type (2018-2029)
4.2 Global Clindamycin Phosphate Topical Revenue by Type (2018-2029)
4.2.1 Global Clindamycin Phosphate Topical Revenue by Type (2018-2023)
4.2.2 Global Clindamycin Phosphate Topical Revenue by Type (2024-2029)
4.2.3 Global Clindamycin Phosphate Topical Revenue Market Share by Type (2018-2029)
4.3 Global Clindamycin Phosphate Topical Price by Type (2018-2029)
5 Segment by Application
5.1 Global Clindamycin Phosphate Topical Sales by Application (2018-2029)
5.1.1 Global Clindamycin Phosphate Topical Sales by Application (2018-2023)
5.1.2 Global Clindamycin Phosphate Topical Sales by Application (2024-2029)
5.1.3 Global Clindamycin Phosphate Topical Sales Market Share by Application (2018-2029)
5.2 Global Clindamycin Phosphate Topical Revenue by Application (2018-2029)
5.2.1 Global Clindamycin Phosphate Topical Revenue by Application (2018-2023)
5.2.2 Global Clindamycin Phosphate Topical Revenue by Application (2024-2029)
5.2.3 Global Clindamycin Phosphate Topical Revenue Market Share by Application (2018-2029)
5.3 Global Clindamycin Phosphate Topical Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Clindamycin Phosphate Topical Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Clindamycin Phosphate Topical Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Perrigo
6.2.1 Perrigo Corporation Information
6.2.2 Perrigo Description and Business Overview
6.2.3 Perrigo Clindamycin Phosphate Topical Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Perrigo Clindamycin Phosphate Topical Product Portfolio
6.2.5 Perrigo Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Clindamycin Phosphate Topical Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Mylan Clindamycin Phosphate Topical Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Ortho Dermatologics
6.4.1 Ortho Dermatologics Corporation Information
6.4.2 Ortho Dermatologics Description and Business Overview
6.4.3 Ortho Dermatologics Clindamycin Phosphate Topical Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ortho Dermatologics Clindamycin Phosphate Topical Product Portfolio
6.4.5 Ortho Dermatologics Recent Developments/Updates
6.5 Taro Pharmaceutical
6.5.1 Taro Pharmaceutical Corporation Information
6.5.2 Taro Pharmaceutical Description and Business Overview
6.5.3 Taro Pharmaceutical Clindamycin Phosphate Topical Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Taro Pharmaceutical Clindamycin Phosphate Topical Product Portfolio
6.5.5 Taro Pharmaceutical Recent Developments/Updates
6.6 Akorn
6.6.1 Akorn Corporation Information
6.6.2 Akorn Description and Business Overview
6.6.3 Akorn Clindamycin Phosphate Topical Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Akorn Clindamycin Phosphate Topical Product Portfolio
6.6.5 Akorn Recent Developments/Updates
6.7 Teligent
6.6.1 Teligent Corporation Information
6.6.2 Teligent Description and Business Overview
6.6.3 Teligent Clindamycin Phosphate Topical Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teligent Clindamycin Phosphate Topical Product Portfolio
6.7.5 Teligent Recent Developments/Updates
6.8 Zydus Pharmaceuticals
6.8.1 Zydus Pharmaceuticals Corporation Information
6.8.2 Zydus Pharmaceuticals Description and Business Overview
6.8.3 Zydus Pharmaceuticals Clindamycin Phosphate Topical Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zydus Pharmaceuticals Clindamycin Phosphate Topical Product Portfolio
6.8.5 Zydus Pharmaceuticals Recent Developments/Updates
6.9 North China Pharmaceutical Group
6.9.1 North China Pharmaceutical Group Corporation Information
6.9.2 North China Pharmaceutical Group Description and Business Overview
6.9.3 North China Pharmaceutical Group Clindamycin Phosphate Topical Sales, Revenue and Gross Margin (2018-2023)
6.9.4 North China Pharmaceutical Group Clindamycin Phosphate Topical Product Portfolio
6.9.5 North China Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Clindamycin Phosphate Topical Industry Chain Analysis
7.2 Clindamycin Phosphate Topical Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Clindamycin Phosphate Topical Production Mode & Process
7.4 Clindamycin Phosphate Topical Sales and Marketing
7.4.1 Clindamycin Phosphate Topical Sales Channels
7.4.2 Clindamycin Phosphate Topical Distributors
7.5 Clindamycin Phosphate Topical Customers
8 Clindamycin Phosphate Topical Market Dynamics
8.1 Clindamycin Phosphate Topical Industry Trends
8.2 Clindamycin Phosphate Topical Market Drivers
8.3 Clindamycin Phosphate Topical Market Challenges
8.4 Clindamycin Phosphate Topical Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Perrigo
Mylan
Ortho Dermatologics
Taro Pharmaceutical
Akorn
Teligent
Zydus Pharmaceuticals
North China Pharmaceutical Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.